I. Garassino

发表

R59ONC-2014-001: An open-label phase II study of regorafenib in patients with metastatic solid tumors who have progressed after standard therapy - RESOUND

A. Santoro, S. Bozzarelli, L. Rimassa, 2015 .

Quality of life of adult cancer survivors enrolled in Humanitas Research Hospital’s survivorship care model

A. Santoro, L. Giordano, I. Garassino, 2022, Supportive Care in Cancer.

Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer.

Armando Santoro, A. Santoro, L. Rimassa, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.

G. Bonadonna, I. Garassino, R. Cavina, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

A. Santoro, I. Garassino, L. di Tommaso, 2012, Ecancermedicalscience.

Herpes Infections in Breast Cancer Patients Treated with Adjuvant Chemotherapy

A. Santoro, I. Garassino, E. Morenghi, 2007, Oncology.

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma

M. Scorsetti, M. Bignardi, P. Mancosu, 2011, Strahlentherapie und Onkologie (Print).

Neoadjuvant Chemoradiotherapy with Volumetric-modulated Arc Therapy for Medium-distal Oesophageal and Gastro-oesophageal Junction Carcinoma.

M. Scorsetti, P. Navarria, L. Cozzi, 2015, Anticancer research.

Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC).

G. Scagliotti, S. Novello, A. Santoro, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

R. Talamini, A. Santoro, I. Garassino, 2008, Lung cancer.

Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up.

G. Ceresoli, M. Alloisio, A. Santoro, 2008, Lung cancer.

Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy.

M. Alloisio, M. Roncalli, L. Giordano, 2009, Breast.

EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?

F. Cappuzzo, G. Ceresoli, A. Santoro, 2007, Expert opinion on medical diagnostics.

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.

E. Giovannetti, G. Giaccone, G. Ceresoli, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer

G. Ceresoli, M. Alloisio, A. Santoro, 2007, Investigational new drugs.

Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose.

I. Garassino, R. Cavina, G. D. De Palo, 2002, European journal of gynaecological oncology.

Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma

F. Cappuzzo, G. Ceresoli, A. Santoro, 2008, Cancer.

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.

R. Talamini, A. Santoro, M. Tiseo, 2010, Lung cancer.

Is gemcitabine cost effective in cancer treatment?

F. Cappuzzo, G. Ceresoli, A. Santoro, 2007, Expert review of pharmacoeconomics & outcomes research.

Irinotecan and raltitrexed: an active combination in advanced colorectal cancer.

A. Santoro, L. Rimassa, I. Garassino, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study

A. Santoro, R. Doci, L. Rimassa, 2007, Investigational New Drugs.

Quality of life of adult cancer survivors enrolled in Humanitas Research Hospital’s survivorship care model

A. Santoro, L. Giordano, I. Garassino, 2022, Supportive Care in Cancer.

Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort.

A. Argiris, I. Garassino, A. Trama, 2021, European journal of cancer.

Unexpected Low Efficacy of Stealth Liposomal Doxorubicin (Caelyx) and Vinorelbine in Metastatic Breast Cancer

A. Santoro, L. Rimassa, I. Garassino, 2004, Breast Cancer Research and Treatment.

Definitive results of hybrid chemotherapy with intravenous (iv) oxaliplatin (OXA) and folinic acid (FA), and intra-hepatic infusion (HAI) of 5-fluorouracil (5-FU) in patients with colorectal liver metastases

L. Rimassa, I. Garassino, C. Carnaghi, 2005 .

Malignant pleural mesothelioma: The gemcitabine-vinorelbine combination in pemetrexed-pretreated patients

G. Ceresoli, A. Santoro, I. Garassino, 2008 .

201 Treatment with gemcitabine and vinorelbine (GEMVIN) as second-line chemotherapy in pemetrexed-pretreated patients with malignant pleural mesothelioma (MPM)

G. Ceresoli, A. Santoro, I. Garassino, 2006 .